In the wake of their oversubscribed capital raising effort, clinical stage pharmaceutical company Pharmaxis (ASX: PXS) is forging ahead with research into their anti-fibrotic drug pipeline. For those unfamiliar with their work, Pharmaxis is developing drugs based on their proprietary amine-oxidase technology. These drugs work by inhibiting an enzyme pathway that is key in the
Read More
It’s no secret that movement is the key to being a healthy individual. Clinical Pilates is one of the more productive ways of moving that might not get your heart rate up as much as that hardcore HIIT class but will deliver countless benefits when it comes to posture, movement, strength and flexibility. The original
Read More
Cancer treatment is slowly shifting away from the standard chemo and radiation and more towards immunotherapy as an alternative treatment. Unlike chemotherapy which destroys healthy, rapidly dividing cells in the body, immunotherapy is more targeted, using the patient’s own immune system to fight cancer. Chemotherapy’s attack on healthy cells causes the well known side effects
Read More
It may be a case of missing the boat for life science company AnteoTech (ASX: ADO) which has been advised by Australian regulators that their submission to have their Rapid Diagnostic Test approved for commercialisation has not met the regulatory requirements, despite a glaring shortage of Rapid Antigen Tests in the community. Additional information was
Read More
Apple Inc. (NASDAQ: AAPL) exhibited their first quarter results on Friday, beating out analyst expectations, showing that the tech giant was able to navigate the global supply chain issues and profit off their new products, including the iPhone 13, new MacBooks, and the Apple Watch Series 7. Sales for the first quarter ending December 25
Read More
Despite the massive surge in online shopping brought upon by the pandemic and subsequent lockdown restrictions, the market has not reacted well to an update from online retailer Kogan.com (ASX:KGN) whose shares tumbled amid profit downgrades. With supply chain disruptions crippling global commerce, some retailers have had a hard time sourcing inventory but in the
Read More